Race, Serum Potassium, and Associations With ESRD and Mortality

American Journal of Kidney Diseases

Volumn 70, Issue 2, 2017, Pages 244-251

  Chen, Yan ^a   Sang, Yingying ^a   Ballew, Shoshana H ^a   Tin, Adrienne ^a   Chang, Alex R ^b   Matsushita, Kunihiro ^a   Coresh, Josef ^a   Kalantar Zadeh, Kamyar ^c   Molnar, Miklos Z ^d,e   Grams, Morgan E ^a,f  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b GEISINGER HEALTH SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^e SEMMELWEIS UNIVERSITY   (Hungary)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

African American; African ancestry; end stage renal disease (ESRD); genetic risk factor; hyperkalemia; hypokalemia; kidney disease; mortality; Race; racial differences; serum potassium

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; POTASSIUM; POTASSIUM SPARING DIURETIC AGENT;

ADULT; ADVERSE OUTCOME; AFRICAN AMERICAN; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; END STAGE RENAL DISEASE; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY RISK; OBSERVATIONAL STUDY; POTASSIUM BLOOD LEVEL; RACE DIFFERENCE; VETERAN; ANCESTRY GROUP; BLOOD; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; MORTALITY; PROSPECTIVE STUDY;

AFRICAN AMERICANS; CONTINENTAL POPULATION GROUPS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POTASSIUM; PROSPECTIVE STUDIES;

EID: 85016786301     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2017.01.044     Document Type: Article

References (37)

1. Hayes, J., Kalantar-Zadeh, K., Lu, J.L., Turban, S., Anderson, J.E., Kovesdy, C.P., Association of hypo-and hyperkalemia with disease progression and mortality in males with chronic kidney disease: the role of race. Nephron Clin Pract 120:1 (2011), c8–c16.
2. Luo, J., Brunelli, S.M., Jensen, D.E., Yang, A., Association between serum potassium and outcomes in patients with reduced kidney function. Clin J Am Soc Nephrol 11:1 (2016), 90–100.
3. Ahmed, A., Zannad, F., Love, T.E., et al. A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure. Eur Heart J 28:11 (2007), 1334–1343.
4. Wang, H.-H., Hung, C.-C., Hwang, D.-Y., et al. Hypokalemia, its contributing factors and renal outcomes in patients with chronic kidney disease. PloS One, 8(7), 2013, e67140.
5. Mattsson, N., Sadjadieh, G., Kumarathurai, P., Nielsen, O.W., Køber, L., Sajadieh, A., Ambulatory cardiac arrhythmias in relation to mild hypokalaemia and prognosis in community dwelling middle-aged and elderly subjects. Europace 18:4 (2016), 585–591.
6. Patel, R.B., Tannenbaum, S., Viana-Tejedor, A., et al. Serum potassium levels, cardiac arrhythmias, and mortality following non-ST-elevation myocardial infarction or unstable angina: insights from MERLIN-TIMI 36. Eur Heart J Acute Cardiovasc Care 6:1 (2017), 18–25.
7. Morris, R.C., Sebastian, A., Forman, A., Tanaka, M., Schmidlin, O., Normotensive salt sensitivity effects of race and dietary potassium. Hypertension 33:1 (1999), 18–23.
8. Gallen, I.W., Rosa, R.M., Esparaz, D.Y., et al. On the mechanism of the effects of potassium restriction on blood pressure and renal sodium retention. Am J Kidney Dis 31:1 (1998), 19–27.
9. Grim, C., Luft, F., Miller, J., et al. Racial differences in blood pressure in Evans County, Georgia: relationship to sodium and potassium intake and plasma renin activity. J Chronic Dis 33:2 (1980), 87–94.
10. Suh, A., DeJesus, E., Rosner, K., et al. Racial differences in potassium disposal. Kidney Int 66:3 (2004), 1076–1081.
11. Gutierrez, O.M., Parsa, A., Isakova, T., et al. Genetic African ancestry and markers of mineral metabolism in CKD. Clin J Am Soc Nephrol 11:4 (2016), 653–662.
12. Kovesdy, C.P., Norris, K.C., Boulware, L.E., et al. Association of race with mortality and cardiovascular events in a large cohort of US veterans. Circulation 132:16 (2015), 1538–1548.
13. Gosmanova, E.O., Lu, J.L., Streja, E., Cushman, W.C., Kalantar-Zadeh, K., Kovesdy, C.P., Association of medical treatment nonadherence with all-cause mortality in newly treated hypertensive US veterans. Hypertension 64:5 (2014), 951–957.
14. Levey, A.S., Stevens, L.A., Schmid, C.H., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 150:9 (2009), 604–612.
15. Grams, M.E., Sang, Y., Coresh, J., et al. Acute kidney injury after major surgery: a retrospective analysis of Veterans Health Administration data. Am J Kidney Dis 67:6 (2016), 872–880.
16. Molnar, M.Z., Kalantar-Zadeh, K., Lott, E.H., et al. Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease. J Am Coll Cardiol 63:7 (2014), 650–658.
17. Kovesdy, C.P., Bleyer, A.J., Molnar, M.Z., et al. Blood pressure and mortality in US veterans with chronic kidney disease: a cohort study. Ann Intern Med 159:4 (2013), 233–242.
18. Grams, M.E., Sang, Y., Coresh, J., et al. Candidate surrogate end points for ESRD after AKI. J Am Soc Nephrol 27:9 (2016), 2851–2859.
19. ARIC Investigators. The Atherosclerosis Risk in Communit (ARIC) Study: design and objectives. Am J Epidemiol 129:4 (1989), 687–702.
20. Patterson, N., Hattangadi, N., Lane, B., et al. Methods for high-density admixture mapping of disease genes. Am J Hum Genet 74:5 (2004), 979–1000.
21. Kao, W.H., Klag, M.J., Meoni, L.A., et al. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 40:10 (2008), 1185–1192.
22. Chatterjee, R., Yeh, H.-C., Shafi, T., et al. Serum and dietary potassium and risk of incident type 2 diabetes mellitus: the Atherosclerosis Risk in Communities (ARIC) study. Arch Intern Med 170:19 (2010), 1745–1751.
23. Alderman, M.H., Piller, L.B., Ford, C.E., et al. Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension 59:5 (2012), 926–933.
24. Chen, Y., Chang, A.R., McAdams DeMarco, M.A., et al. Serum potassium, mortality, and kidney outcomes in the Atherosclerosis Risk in Communities Study. Mayo Clinic Proc 91:10 (2016), 1403–1412.
25. Reich, D., Nalls, M.A., Kao, W.H., et al. Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene. PLoS Genet, 5(1), 2009, e1000360.
26. Meyer, T.E., Verwoert, G.C., Hwang, S.J., et al. Genome-wide association studies of serum magnesium, potassium, and sodium concentrations identify six loci influencing serum magnesium levels. PLoS Genet, 6(8), 2010.
27. Tin, A., Kottgen, A., Folsom, A.R., et al. Genetic loci for serum magnesium among African-Americans and gene-environment interaction at MUC1 and TRPM6 in European-Americans: the Atherosclerosis Risk in Communities (ARIC) study. BMC Genet, 16, 2015, 56.
28. Palmer, B.F., Clegg, D.J., Hyperkalemia. JAMA 314:22 (2015), 2405–2406.
29. Palmer, B.F., Clegg, D.J., Electrolyte and acid-base disturbances in patients with diabetes mellitus. N Engl J Med 373:6 (2015), 548–559.
30. Palmer, B.F., Clegg, D.J., Achieving the benefits of a high-potassium, paleolithic diet, without the toxicity. Mayo Clin Proc 91:4 (2016), 496–508.
31. Turban, S., Miller, E.R. 3rd, Ange, B., Appel, L.J., Racial differences in urinary potassium excretion. J Am Soc Nephrol 19:7 (2008), 1396–1402.
32. Turban, S., Thompson, C.B., Parekh, R.S., Appel, L.J., Effects of sodium intake and diet on racial differences in urinary potassium excretion: results from the Dietary Approaches to Stop Hypertension (DASH)-Sodium trial. Am J Kidney Dis 61:1 (2013), 88–95.
33. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Urinary and serum electrolytes in untreated black and white hypertensives. J Chronic Dis 40:9 (1987), 839–847.
34. Cohall, D., Scantlebury-Manning, T., Rafie, C., James, S., Hall, K., Dietary potassium intake and renal handling, and their impact on the cardiovascular health of normotensive Afro-Caribbeans. West Indian Med J 63:1 (2014), 13–19.
35. Barlow, R.J., Connell, M.A., Milne, F.J., A study of 48-hour faecal and urinary electrolyte excretion in normotensive black and white South African males. J Hypertens 4:2 (1986), 197–200.
36. James, P.A., Oparil, S., Carter, B.L., et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth Joint National Committee (JNC 8). JAMA 311:5 (2014), 507–520.
37. Potter, W.Z., Trygstad, C.W., Helmer, O.M., Nance, W.E., Judson, W.E., Familial hypokalemia associated with renal interstitial fibrosis. Am J Med 57:6 (1974), 971–977.